Contribution: Industrial Research Assistance Program – Contributions to Firms
BioScision Diagnostics Inc.
$0.00
Bringing Animal Health Drug Manufacturing to Manitoba
EF 2025-26 · 2025-07-28
Résumé
BioScision Diagnostics operates in a 65,000 SF drug manufacturing facility in Winnipeg Manitoba. BioScision will leverage its advanced drug manufacturing facility and experience to begin formulating, compounding, filling, finishing and testing, and distributing in-demand off-patent essential animal health drugs.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Winnipeg|Winnipeg, Manitoba, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
794779660
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2025-07-28 | 2025-26 | $120,000.00 |
| 1 | 2025-07-28 | 2025-26 | $0.00 |
Tel que publié
Agreement End Date
2026-09-30
Agreement Number
1036844
Agreement Start Date
2025-07-28
Agreement Title
Bringing Animal Health Drug Manufacturing to Manitoba
Agreement Title (French)
Implanter la fabrication de médicaments pour la santé animale au Manitoba
Agreement Type
Contribution
Agreement Value
$0.00
Amendment Date
2026-07-01
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
BioScision Diagnostics operates in a 65,000 SF drug manufacturing facility in Winnipeg Manitoba. BioScision will leverage its advanced drug manufacturing facility and experience to begin formulating, compounding, filling, finishing and testing, and distributing in-demand off-patent essential animal health drugs.
Description (French)
BioScision Diagnostics exploite une usine de fabrication de médicaments de 65 000 pieds carrés à Winnipeg, au Manitoba. BioScision mettra à profit son usine de fabrication de médicaments de pointe et son expérience pour commencer à formuler, composer, remplir, finir, tester et distribuer des médicaments essentiels pour la santé animale qui sont en demande et dont le brevet a expiré.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Winnipeg South
Federal Riding (French)
Winnipeg-Sud
Federal Riding Number
46013
NAICS Code
541380
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
794779660
Recipient City
Winnipeg|Winnipeg
Recipient Country
CA
Recipient Legal Name
BioScision Diagnostics Inc.
Recipient Operating Name
Bioscision
Recipient Postal Code
R3Y 1G4
Recipient Province or Territory
MB
Recipient Type
F
Reference Number
172-2025-2026-Q3-1036844
